Is The Incidence Of Heart Attack Still Decreasing In Australia? Developing More Reliable Methods For Monitoring Trends In Myocardial Infarction And Coronary Heart Disease
Funder
National Health and Medical Research Council
Funding Amount
$762,021.00
Summary
Our study is a collaboration between the University of WA and the Australian Institute of Health and Welfare to investigate population trends in incidence and outcomes of heart disease and its major sub-groups including heart attack, angina and chest pain. Using linked data from WA, we will identify the sub-groups for which trends over time are a realistic estimate of the true population trends. These will be applied to national data to monitor heart disease more accurately in Australia.
Advancing The Epidemiology Of Coronary Heart Disease: Reliable Monitoring, Secondary Prevention And Future Projections
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Coronary heart disease imposes a significant health care burden in Australia, and there have been major changes to the way in which this disease is diagnosed and treated. This project will develop a new method for accurate monitoring of the burden of coronary heart disease nationally, will assess the effectiveness of current drug treatments for people with coronary heart disease and estimate future rates of coronary heart disease in the whole population.
Osteoporotic Fracture-Mortality Association And The Effect Of Anti-osteoporosis Treatment: A Multinational Study
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
Osteoporosis burden is due primarily to osteoporotic fractures resulting in economic and public health burden, increased disability, further fracture risk and more importantly early death. However, it remains under-treated although treatment reduces the number of fractures and may reduce early death. This study aims to understand which types of fractures result in early death and for which age groups and whether osteoporosis treatment does or does not reduce early death.
Prevention Of Multi-drug Resistant Tuberculosis In A High Prevalence Setting: ‘Connecting The DOTS’ In Vietnam
Funder
National Health and Medical Research Council
Funding Amount
$3,382,020.00
Summary
The close contacts of people with multi-drug resistant tuberculosis (MDR-TB) have a high risk of developing the disease. The V-QUIN MDR-TB Trial will evaluate the effectiveness of an oral antibiotic (levofloxacin) in preventing drug resistant TB among infected household contacts of TB patients. Household contacts from 10 Provinces in Vietnam will be randomly allocated to receive six-months of either levofloxacin or a placebo, and then followed for two years to see if they develop tuberculosis.
Testing And Treatment For Prostate Cancer In Australia: Epidemiology And Modelling
Funder
National Health and Medical Research Council
Funding Amount
$267,886.00
Summary
We aim to use observational data and mathematical modelling to investigate testing and treatment for prostate cancer in Australia. We will incorporate changes in prostate-specific antigen (PSA) testing and in clinical practice to investigate: a) over-diagnosis, being cancer cases diagnosed through PSA testing that would not have been otherwise diagnosed; b) the effect of PSA testing on prostate cancer mortality; and c) mortality and health care use under different PSA test scenarios.